Opinion/decision on a Paediatric investigation plan (PIP): Sirturo,bedaquiline fumarate, decision type: , therapeutic area: , PIP number: P/0470/2022
Template for scientific document (part B-F)
Medicinal products for human use: monthly figures - October 2023
Procurement
Scientific advice and protocol assistance adopted during the CHMP meeting of 6-9 November 2023
CTIS newsflash – 10 November 2023
Clinical Trial Information System (CTIS) - Sponsor handbook
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Multiple Sclerosis, Date of authorisation: 08/01/2018, Revision: 18, Status: Authorised
Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers for marketing authorisation holders / applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products
Scientific recommendations on classification of advanced therapy medicinal products (January 2021 - September 2023)